ArticleTranslational lung cancer research2024

TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemoradiotherapy (R-ALPS): study protocol for a randomized, double-blind, placebo-controlled, multicenter phase III trial.

Baiqiang Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.